Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATC Combination in Metastatic or Locally Advanced Breast Cancer
NCT00003352Phase 2Completed
- Sponsor
- NSABP Foundation
- Start
- Jun 1998
- Primary completion
- Sep 2000
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 3
01
Overview
A Phase 2 trial of pegylated liposomal doxorubicin, docetaxel, cyclophosphamide in breast cancer, sponsored by NSABP Foundation. Started Jun 1998; status: completed.
02
Drugs
pegylated liposomal doxorubicindocetaxelcyclophosphamide
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00003352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003352.